This list of important factors is not intended to be exhaustive. Our medical directors play vital roles in everything from case review to acting as spokespersons advocating for healthy behaviors to shape and promote initiatives that improve the health of millions of members. If you experience a severe reaction, contact your healthcare provider or visit the Vaccine Adverse Event Reporting System. We are sorry for the inconvenience. These forward-looking statements reflect our current views with respect to future events and are based on numerous assumptions and assessments made by us in light of our experience and perception of historical trends, current conditions, business strategies, operating environments, future developments and other factors we believe appropriate. The phased approach addresses and prioritizes vaccination for healthcare workers, people in long-term care facilities, and certain groups of essential workers and first responders. Founded in 1933 and based in Eugene, OR, with offices in Oregon, Idaho and Montana, PacificSource serves ~ 260,000 members (Commercial . Ajude-nos a manter o Glassdoor seguro confirmando que voc uma pessoa de Prior to joining HealthMarkets, Mr. Fasola spent nearly twenty years in executive leadership roles at UnitedHealth Group and Humana. Mr. Thomas received a bachelor's degree in Sociology from the University at Albany and a Master of Business Administration from the Zicklin School of Business at Baruch College in Manhattan. These statements are not guarantees of future performance and are subject to risks, uncertainties and assumptions. I have been consistently impressed by Sarah's passion to serve our members, who are often the most vulnerable amongst us. But we have to recognize that people are seeking information from a number of different sources, so we need to be willing to engage wherever theyre looking.. corporate governance. Centene Corporation About Dr. Alice Hm Chen is chief health office for Centene, the largest Medicaid and Marketplace managed care organization in the U.S., where she is responsible for. Mr. LeClaire received a Bachelor of the Arts in Psychology from Ripon College; a Master of Business Administration in Accounting from the University of Wisconsin, Oshkosh; and a PhD in Management Information Systems, with a minor in Computer Science, from Oklahoma State University. Ken Fasola, currently Executive Vice President (EVP) of Health Care Enterprises, will become President of Centene, continuing to report to Sarah London. Previously, he was President and COO for Magellan Health where he oversaw the Magellan Behavioral and Specialty Health and Magellan Complete Care business segments. Before joining Centene in 2020, Ms. London was a Partner at Optum Ventures, the venture capital arm of UnitedHealth Group. Aydanos a proteger Glassdoor y demustranos que eres una persona real. You should not place undue reliance on any forward-looking statements, as actual results may differ materially from projections, estimates, or other forward-looking statements due to a variety of important factors, variables and events including, but not limited to:our ability to accurately predict and effectively manage health benefits and other operating expenses and reserves, including fluctuations in medical utilization rates due to the impact of COVID-19; the risk that the election of new directors, changes in senior management and inability to retain key personnel may create uncertainty or negatively impact our ability to execute quickly and effectively;uncertainty as to the expected financial performance of the combined company following the recent completion of the Magellan Acquisition; the possibility that the expected synergies and value creation from the Magellan Acquisition or the WellCare Acquisition (or other acquired businesses) will not be realized, or will not be realized within the respective expected time periods; the risk that unexpected costs will be incurred in connection with the integration of the Magellan Acquisition or that the integration of Magellan Health will be more difficult or time consuming than expected, or similar risks from other acquisitions we may announce or complete from time to time; disruption from the integration of the Magellan Acquisition or from the integration of the WellCare Acquisition, or similar risks from other acquisitions we may announce or complete from time to time, including potential adverse reactions or changes to business relationships with customers, employees, suppliers or regulators, making it more difficult to maintain business and operational relationships; a downgrade of the credit rating of our indebtedness; competition; membership and revenue declines or unexpected trends; changes in healthcare practices, new technologies, and advances in medicine; increased healthcare costs; changes in economic, political or market conditions; changes in federal or state laws or regulations, including changes with respect to income tax reform or government healthcare programs as well as changes with respect to the Patient Protection and Affordable Care Act and the Health Care and Education Affordability Reconciliation Act (collectively referred to as the ACA) and any regulations enacted thereunder that may result from changing political conditions, the new administration or judicial actions; rate cuts or other payment reductions or delays by governmental payors and other risks and uncertainties affecting our government businesses; our ability to adequately price products; tax matters; disasters or major epidemics; changes in expected contract start dates; provider, state, federal, foreign and other contract changes and timing of regulatory approval of contracts; the expiration, suspension, or termination of our contracts with federal or state governments (including, but not limited to, Medicaid, Medicare, TRICARE or other customers); the difficulty of predicting the timing or outcome of legal or regulatory proceedings or matters, including, but not limited to, our ability to resolve claims and/or allegations made by states with regard to past practices, including at Envolve Pharmacy Solutions, Inc. (Envolve), as our pharmacy benefits manager (PBM) subsidiary, within the reserve estimate we have recorded and on other acceptable terms, or at all, or whether additional claims, reviews or investigations relating to our PBM business will be brought by states, the federal government or shareholder litigants, or government investigations; timing and extent of benefits from strategic value creation initiatives, including the possibility that these initiatives will not be successful, or will not be realized within the expected time periods; challenges to our contract awards; cyber-attacks or other privacy or data security incidents; the exertion of management's time and our resources, and other expenses incurred and business changes required in connection with complying with the undertakings in connection with any regulatory, governmental or third party consents or approvals for acquisitions; changes in expected closing dates, estimated purchase price and accretion for acquisitions; the risk that acquired businesses will not be integrated successfully;restrictions and limitations in connection with our indebtedness; our ability to maintain or achieve improvement in the Centers for Medicare and Medicaid Services (CMS) Star ratings and maintain or achieve improvement in other quality scores in each case that can impact revenue and future growth; availability of debt and equity financing, on terms that are favorable to us; inflation; foreign currency fluctuations and risks and uncertainties discussed in the reports that Centene has filed with the Securities and Exchange Commission. Mr. LeClaire received a Bachelor of the Arts in Psychology from Ripon College; a Master of Business Administration in Accounting from the University of Wisconsin, Oshkosh; and a PhD in Management Information Systems, with a minor in Computer Science, from Oklahoma State University. Dr. Yamaguchi received a dose of the vaccine at Barnes-Jewish Hospital in St. Louis, Missouri (pictured). Part of the reason she is at Wellcare is that she believes the private sector can play an important role in improving health outcomes. All statements, other than statements of current or historical fact, contained in this press release are forward-looking statements. She also has a Master of Public Health in Health Care Management and Policy from Harvard School of Public Health. Dave Thomas most recently served as Centene's Executive Vice President, Markets where he was responsible for the oversight of Centene's 31 health plans nationwide. Prior to that he was a Vice President of Product Development at Alltel, a wireless service provider acquired by Verizon Wireless. By their nature, forward-looking statements involve known and unknown risks and uncertainties and are subject to change because they relate to events and depend on circumstances that will occur in the future, including economic, regulatory, competitive and other factors that may cause our or our industry's actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. All statements, other than statements of current or historical fact, contained in this press release are forward-looking statements. Equipped with deep experience in operations spanning a career of nearly three decades, Mr. Murray will be critical to Centene's efforts in value creation, quality, and core business operations. Prior to Health Net, Koenig advised Centene Corporation in California for more than 10 years as the principal at his consulting firm . Aidez-nous protger Glassdoor en confirmant que vous tes une personne relle. This Hispanic Heritage Month, were highlighting the contributions of Hispanic and Latinx medical directors and chief medical officers across Centene health plans. Ken Fasola named President of Centene Jim Murray named Chief Operating Officer Brent Layton becomes Senior Advisor to the CEO Dave Thomas becomes Chief Executive Officer of Markets and. Its vital that access to the COVID-19 vaccine is swift and widespread to ensure herd immunity. Mr. Neidorff remains on a previously announced medical leave of absence from his position on the Board of the Company. Lamentamos Brent Layton becomes Senior Advisor to the CEO, Dave Thomas becomes Chief Executive Officer of Markets and Medicaid, Additionally, Company appoints Alice H. Chen, MD, MPH as Chief Health Officer and Brian LeClaire, MBA, PhD, as Chief Information Officer. Prior to this position, he was the Sam and Marilyn Fox . In particular, these statements include, without limitation, statements about our future operating or financial performance, market opportunity, value creation strategy, competition, expected activities in connection with completed and future acquisitions and dispositions, our investments and the adequacy of our available cash resources. The health of individuals drives our focus on the environment, She also has a Master of Public Health in Health Care Management and Policy from Harvard School of Public Health. Ci In her management role, Ms. London led the Company's technology and digital strategy in addition to running the Health Care Enterprises and Specialty divisions, Corporate Strategy, Quality Operations, Internal Audit, Compliance and Risk Management. The Company takes a local approach with local brands and local teams to provide fully integrated, high-quality, and cost-effective services to government-sponsored and commercial healthcare programs, focusing on under-insured and uninsured individuals. As a practicing physician. With extensive leadership and more than 20 years of experience in the managed care industry, Mr. Thomas will take on an expanded scope and responsibility for the Medicaid product and business development. All forward-looking statements included in this press release are based on information available to us on the date hereof. Si vous continuez voir ce Sie weiterhin diese Meldung erhalten, informieren Sie uns darber bitte per E-Mail Leadership and Officers listed above. pour nous faire part du problme. Dr. Guerra has made reaching Hispanic populations in the Louisville area a focus. Dr. Ken Yamaguchi, Centene Executive Vice President & Chief Medical Officer, has firsthand experience with the COVID-19 vaccine. Chief Medical Officer Centene Corporation ST. LOUIS, April 27, 2015 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced the appointment of Ken Yamaguchi, M.D., to Executive Vice President and Chief Medical Officer, effective . Without limiting the foregoing, forward-looking statements often use words such as "believe," "anticipate," "plan," "expect," "estimate," "intend," "seek," "target," "goal," "may," "will," "would," "could," "should," "can," "continue" and other similar words or expressions (and the negative thereof). Prior to that, he was Chairman, President, and CEO of HealthMarkets, Inc., one of the largest health insurance agencies and supplemental insurance companies in the U.S. HealthMarkets was acquired by UnitedHealth Group in 2019. Dr. Chen received a Bachelor of Science in Environmental Biology from Yale University and has a Doctor of Medicine from the Stanford University School of Medicine. David P. Thomas, CEO, Markets and Medicaid, Centene Corporation. The Company takes a local approach with local brands and local teams to provide fully integrated, high-quality, and cost-effective services to government-sponsored and commercial healthcare programs, focusing on under-insured and uninsured individuals. Centene.com uses cookies. ST. LOUIS, March 22, 2022 /PRNewswire/ --Centene Corporation (NYSE: CNC) announced today that Sarah London, Vice Chairman of Centene, has been appointed Chief Executive Officer, effective immediately, succeeding Michael Neidorff. Most COVID-19 vaccines require two injections; the first starts building protection and the second is given a few weeks later. Prior to her appointment as CEO, Ms. London served as Vice Chairman of the Centene Board of Directors. Wir entschuldigen uns fr die Umstnde. Brent Layton will become Senior Advisor to the CEO, as he begins his transition towards retirement. Dave Thomas most recently served as Centene's Executive Vice President, Markets where he was responsible for the oversight of Centene's 31 health plans nationwide. The Company also contracts with other healthcare and commercial organizations to provide a variety of specialty services focused on treating the whole person. healthcare services. Learn how Chief Medical Officer for Wellcare in Kentucky, Dr. Sandra Guerra, has worked to reach Hispanic communities during the COVID-19 pandemic to promote the importance of vaccines. Chief Health Officer. Prior to that he served as CEO of UnitedHealth Care's Central Region, President of UnitedHeathcare lines of business and National Sales Officer. Since joining Centene in 2006, he has overseen the development and implementation of new health plans in more than 25 states, provided strategic guidance to state governments to help them develop effective Medicaid solutions, and developed new business contracting with providers and health systems where he led the company's effort in value-based purchasing. Dave Thomas, currently EVP, Markets, will become CEO of Markets and Medicaid, reporting into Mr. Fasola. Transforming the health of the community, one person at a time. Dave joined Fidelis in 1999 as Director of Strategic Planning and Development and held positions of increasing responsibility during his tenure from Vice President, Senior Vice President of Operations, Senior Vice President and Chief Administrative Officer, and Executive Vice President and Chief Operating Officer culminating in leading the organization. Average Centene Chief Medical Officer yearly pay in the United States is approximately $306,170, which is 28% above the national average. As CIO, Mr. LeClaire will be responsible for Centene's information technology strategy, ensuring its alignment with the Company's business strategy, and delivering secure, differentiated technology-enabled experiences to members. The Company also contracts with other healthcare and commercial organizations to provide a variety of specialty services focused on treating the whole person. Prior to joining Centene, Dr. Chen was Chief Medical Officer at Covered California, the states health insurance marketplace, where she was responsible for healthcare strategy focused on quality, equity and delivery system transformation. Mr. Murray received his bachelor's degree in accounting from the University of Dayton and is a certified public accountant. Dr. Chen was also a professor of medicine at the University of California San Francisco School of Medicine, based at the Zuckerberg San Francisco General Hospital, where she served as its Chief Integration Officer and founding director of the eConsult program. Brent Layton, President and Chief Operating Officer of Centene, stated, "Sarah brings a tremendous skillset to the leadership of Centene Corporation, and I'm excited to partner closely with her as Centene begins our journey into the next era of our history. Jim Murray, EVP, Chief Operating Officer, Centene Corporation. Previously he served as Senior Vice President and Chief Information Officer for Humana, where he spent more than two decades in various technology and operational leadership roles. Lamentamos pelo inconveniente. Biography. envie um e-mail para These statements are not guarantees of future performance and are subject to risks, uncertainties and assumptions. 418 followers 402 connections. Magna Cum Laude in History & Literature from Harvard College, where she played Division I tennis. By their nature, forward-looking statements involve known and unknown risks and uncertainties and are subject to change because they relate to events and depend on circumstances that will occur in the future, including economic, regulatory, competitive and other factors that may cause our or our industry's actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Mr. Fasola holds a Bachelor of Science in Health Planning and Administration from Pennsylvania State University and was named an Alumni Fellow in 2010. Centene.com uses cookies. A: I didnt. As the COVID-19 pandemic evolves, different prevention strategies emerge, including immunization. naar Centene Corporation, a Fortune 500 company, is a leading healthcare enterprise that is committed to helping people live healthier lives. Please help us protect Glassdoor by verifying that you're a Onze Ken Fasola brings more than three decades of successful leadership in the healthcare industry, having most recently served as Centene's Executive Vice President of Health Care Enterprises and a member of the Office of the CEO. Disculpa She previously served as Deputy Secretary for Policy and Planning and Chief of Clinical Affairs for the California Health and Human Services Agency, where she led signature health policy initiatives on affordability and access and played a leadership role in the state's response to the COVID-19 pandemic. Centene offers affordable and high-quality products to nearly 1 in 15 individuals across the nation, including Medicaid and Medicare members (including Medicare Prescription Drug Plans) as well. Because of the language barrier, many Hispanic Kentuckians may have already faced health access issues, which is one of the reasons why the virus has had a disproportionate impact in this community, but Dr. Guerra has also noticed the impact that misinformation found on social media can have on compounding disparities. Centene (the Company, our, or we) intends such forward-looking statements to be covered by the safe-harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and we are including this statement for purposes of complying with these safe-harbor provisions. You should not place undue reliance on any forward-looking statements, as actual results may differ materially from projections, estimates, or other forward-looking statements due to a variety of important factors, variables and events including, but not limited to: our ability to accurately predict and effectively manage health benefits and other operating expenses and reserves, including fluctuations in medical utilization rates due to the ongoing impact of COVID-19; our ability to maintain or achieve improvement in the Centers for Medicare and Medicaid Services (CMS) Star ratings and maintain or achieve improvement in other quality scores in each case that can impact revenue and future growth; the risk that the election of new directors, changes in senior management, and any inability to retain key personnel may create uncertainty or negatively impact our ability to execute quickly and effectively; uncertainty as to the expected financial performance of the combined company following the recent completion of the acquisition of Magellan Health, Inc. (the Magellan Acquisition); the possibility that the expected synergies and value creation from the Magellan Acquisition or the acquisition of WellCare Health Plans, Inc. (the WellCare Acquisition) (or other acquired businesses) will not be realized, or will not be realized within the respective expected time periods; disruption from the integration of the Magellan Acquisition or from the integration of the WellCare Acquisition; unexpected costs, or similar risks, from other acquisitions or dispositions we may announce or complete from time to time, including potential adverse reactions or changes to business relationships with customers, employees, suppliers or regulators, making it more difficult to maintain business and operational relationships; the risk that the closing conditions, including applicable regulatory approvals, for the pending disposition of Magellan Specialty Health may be delayed or not obtained; impairments to real estate, investments, goodwill and intangible assets; a downgrade of the credit rating of our indebtedness; competition; membership and revenue declines or unexpected trends; changes in healthcare practices, new technologies, and advances in medicine; increased healthcare costs; changes in economic, political or market conditions; changes in federal or state laws or regulations, including changes with respect to income tax reform or government healthcare programs as well as changes with respect to the Patient Protection and Affordable Care Act and the Health Care and Education Affordability Reconciliation Act (collectively referred to as the ACA) and any regulations enacted thereunder that may result from changing political conditions, the current administration or judicial actions; rate cuts or other payment reductions or delays by governmental payors and other risks and uncertainties affecting our government businesses; our ability to adequately price products; tax matters; disasters or major epidemics; changes in expected contract start dates; provider, state, federal, foreign and other contract changes and timing of regulatory approval of contracts; the expiration, suspension, or termination of our contracts with federal or state governments (including, but not limited to, Medicaid, Medicare, TRICARE or other customers); the difficulty of predicting the timing or outcome of legal or regulatory proceedings or matters, including, but not limited to, our ability to resolve claims and/or allegations made by states with regard to past practices, including at Envolve Pharmacy Solutions, Inc. (Envolve), as our pharmacy benefits manager (PBM) subsidiary, within the reserve estimate we previously recorded and on other acceptable terms, or at all, or whether additional claims, reviews or investigations relating to our PBM business will be brought by states, the federal government or shareholder litigants, or government investigations; the timing and extent of benefits from our value creation strategy, including the possibility that the benefits received may be lower than expected, may not occur, or will not be realized within the expected time periods; challenges to our contract awards; cyber-attacks or other privacy or data security incidents; the exertion of management's time and our resources, and other expenses incurred and business changes required in connection with complying with the undertakings in connection with any regulatory, governmental or third party consents or approvals for acquisitions or dispositions; any changes in expected closing dates, estimated purchase price and accretion for acquisitions or dispositions; restrictions and limitations in connection with our indebtedness; the availability of debt and equity financing on terms that are favorable to us; inflation; foreign currency fluctuations; and risks and uncertainties discussed in the reports that Centene has filed with the Securities and Exchange Commission. Financial and other information about Centene is routinely posted and is accessible on Centene's investor relations website, https://investors.centene.com/. He will be responsible for Centene's health plans, all lines of business and core operations. Previously, he was President and CEO of Fidelis Care where he led oversight across all divisions of Fidelis Care. At Humana Mr. Fasola was the COO of Market Operations and formerly a member of the Office of the Chairman, a role he assumed after thirteen years leading various divisions within the company. Murray also served as Executive Vice President and Chief Operating Officer for Humana and held other significant leadership roles over a career spanning nearly three decades. Jim Murray, currently EVP, Chief Transformation Officer, will become EVP, Chief Operating Officer (COO), reporting to Mr. Fasola. . "Sarah has infused an innovative mindset across the enterprise in her relentless effort to improve Centene's capabilities to provide the highest quality of care for our members. Transforming the health of the community, one person at a time. Brent Layton has more than 30 years of experience with increasing responsibility in the healthcare and public policy sectors, with particular expertise in creating, scaling, and operating business in a highly regulated environment. Prior to her appointment as CEO, Ms. London served as Vice Chairman of the Company, and in her management role was responsible for a portfolio of companies independent of Centene's health plans, designing differentiated platform capabilities, and delivering industry-leading products and services to third-party customers. The pandemic has underlined how important it is for clinicians to look for as many avenues as possible to convey factual information and meet people where they are. Except as may be otherwise required by law, we undertake no obligation to update or revise the forward-looking statements included in this press release, whether as a result of new information, future events or otherwise, after the date hereof.